Janet Dillione - Feb 22, 2022 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role
Director
Signature
/s/ Janet Dillione
Stock symbol
CRMD
Transactions as of
Feb 22, 2022
Transactions value $
$0
Form type
4
Date filed
2/23/2022, 04:43 PM
Next filing
Jan 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CRMD Common Stock 53.5K Feb 22, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRMD Stock Option (Right to Buy Common Stock) Award $0 +20K $0.00 20K Feb 22, 2022 Common Stock 20K $4.03 Direct F9
holding CRMD Stock Option (Right to Buy Common Stock) 30K Feb 22, 2022 Common Stock 30K $8.32 Direct F1
holding CRMD Phantom Stock 3.58K Feb 22, 2022 Common Stock 3.58K $0.00 Direct F2
holding CRMD Phantom Stock 4.77K Feb 22, 2022 Common Stock 4.77K $0.00 Direct F2
holding CRMD Phantom Stock 5.25K Feb 22, 2022 Common Stock 5.25K $0.00 Direct F2
holding CRMD Stock Option (Right to Buy Common Stock) 15K Feb 22, 2022 Common Stock 15K $5.63 Direct F3
holding CRMD Phantom Stock 1.71K Feb 22, 2022 Common Stock 1.71K $0.00 Direct F2
holding CRMD Phantom Stock 2.1K Feb 22, 2022 Common Stock 2.1K $0.00 Direct F2
holding CRMD Phantom Stock 945 Feb 22, 2022 Common Stock 945 $0.00 Direct F2
holding CRMD Phantom Stock 1.13K Feb 22, 2022 Common Stock 1.13K $0.00 Direct F2
holding CRMD Phantom Stock 843 Feb 22, 2022 Common Stock 843 $0.00 Direct F2
holding CRMD Stock Option (Right to Buy Common Stock) 15K Feb 22, 2022 Common Stock 15K $8.30 Direct F4
holding CRMD Phantom Stock 1.33K Feb 22, 2022 Common Stock 1.33K $0.00 Direct F2
holding CRMD Phantom Stock 2.73K Feb 22, 2022 Common Stock 2.73K $0.00 Direct F2
holding CRMD Phantom Stock 7.5K Feb 22, 2022 Common Stock 7.5K $0.00 Direct F2
holding CRMD Stock Option (Right to Buy Common Stock) 8K Feb 22, 2022 Common Stock 8K $2.85 Direct F5
holding CRMD Phantom Stock 2.68K Feb 22, 2022 Common Stock 2.68K $0.00 Direct F2
holding CRMD Phantom Stock 3.13K Feb 22, 2022 Common Stock 3.13K $0.00 Direct F2
holding CRMD Phantom Stock 4.17K Feb 22, 2022 Common Stock 4.17K $0.00 Direct F2
holding CRMD Stock Option (Right to Buy Common Stock) 8K Feb 22, 2022 Common Stock 8K $11.20 Direct F6
holding CRMD Phantom Stock 695 Feb 22, 2022 Common Stock 695 $0.00 Direct F2
holding CRMD Phantom Stock 829 Feb 22, 2022 Common Stock 829 $0.00 Direct F2
holding CRMD Stock Option (Right to Buy Common Stock) 10K Feb 22, 2022 Common Stock 10K $15.15 Direct F7
holding CRMD Phantom Stock 283 Feb 22, 2022 Common Stock 283 $0.00 Direct F2
holding CRMD Stock Option (Right to Buy Common Stock) 19K Feb 22, 2022 Common Stock 19K $9.55 Direct F8
holding CRMD Phantom Stock 767 Feb 22, 2022 Common Stock 767 $0.00 Direct F2
holding CRMD Phantom Stock 554 Feb 22, 2022 Common Stock 554 $0.00 Direct F2
holding CRMD Phantom Stock 867 Feb 22, 2022 Common Stock 867 $0.00 Direct F2
holding CRMD Phantom Stock 3.06K Feb 22, 2022 Common Stock 3.06K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options were granted on 1/11/2021. These options are fully vested.
F2 Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.
F3 These options were granted on 02/25/2020. These options are fully vested.
F4 These options were granted on 01/10/2019. These options are fully vested.
F5 These options were granted on 02/16/2018. These options are fully vested.
F6 These options were granted on 02/21/2017. These options are fully vested.
F7 These options were granted on 08/12/2015. These options are fully vested.
F8 These options were granted on 02/21/2016. These options are fully vested.
F9 These options were granted on 2/22/2022. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.

Remarks:

The Issuer effected a 1-for-5 reverse stock split of its common stock on March 26, 2019. All share and per share exercise price amounts shown in this Form 4 have been adjusted to reflect the reverse stock split.